UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review

Blood cancer journal (New York), 2024-02, Vol.14 (1), p.24-24, Article 24

2024

Link zum Volltext

Verfügbarkeit prüfen

S170: DYNAMIC INTERPLAY BETWEEN TUMOR AND MICRO‐ENVIRONMENT DURING MYELOMA DISEASE PROGRESSION

HemaSphere, 2022-06, Vol.6, p.71-72

2022

Link zum Volltext

Verfügbarkeit prüfen

Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study

Annals of hematology, 2021-04, Vol.100 (4), p.1065-1077

2021

Link zum Volltext

Verfügbarkeit prüfen

Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results

Journal of cancer research and clinical oncology, 2021-02, Vol.147 (2), p.619-631

2021

Link zum Volltext

Verfügbarkeit prüfen

Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Blood cancer journal (New York), 2016-09, Vol.6 (9), p.e471

2016

Link zum Volltext

Verfügbarkeit prüfen

Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Blood cancer journal (New York), 2016-07, Vol.6 (7), p.e453-e453

2016

Link zum Volltext

Verfügbarkeit prüfen

Inhibiting MEK in MAPK pathway-activated myeloma

Leukemia, 2016-04, Vol.30 (4), p.976-980

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical value of molecular subtyping multiple myeloma using gene expression profiling

Leukemia, 2016-02, Vol.30 (2), p.423-430

2016

Link zum Volltext

Verfügbarkeit prüfen

Common genetic variants in 11q13.3 and 9q22.33 are associated with molecular subgroups of multiple myeloma

Leukemia, 2015-12, Vol.29 (12), p.2418-2421

2015

Link zum Volltext

Verfügbarkeit prüfen

Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120)

Haematologica (Roma), 2015-09, Vol.100 (9), p.1214

2015

Link zum Volltext

Verfügbarkeit prüfen

The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myeloma

Leukemia, 2015-08, Vol.29 (8), p.1713-1720

2015

Link zum Volltext

Verfügbarkeit prüfen

Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma

Leukemia, 2014-12, Vol.28 (12), p.2410-2413

2014

Link zum Volltext

Verfügbarkeit prüfen

Serial exome analysis of disease progression in premalignant gammopathies

Leukemia, 2014-07, Vol.28 (7), p.1548-1552

2014

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic progenitor cell collection after autologous transplant for multiple myeloma: low platelet count predicts for poor collection and sole use of resulting graft enhances risk of myelodysplasia

Leukemia, 2014-04, Vol.28 (4), p.888-893

2014

Link zum Volltext

Verfügbarkeit prüfen

Reply to "Metronomic chemotherapy beyond misconceptions"--Haematologica 2013;98(11):e145

Haematologica (Roma), 2013-11, Vol.98 (11), p.e149-e150

2013

Link zum Volltext

Verfügbarkeit prüfen

Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma

Haematologica (Roma), 2013-07, Vol.98 (7), p.1147-1153

2013

Link zum Volltext

Verfügbarkeit prüfen

Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols

Leukemia, 2012-11, Vol.26 (11), p.2398-2405

2012

Link zum Volltext

Verfügbarkeit prüfen

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

Haematologica (Roma), 2012-11, Vol.97 (11), p.1761-1767

2012

Link zum Volltext

Verfügbarkeit prüfen

Report on the International Symposium on Low Molecular Weight Heparins and Related Polysaccharides : Munich, Germany, June 27 and 28, 1991

Seminars in thrombosis and hemostasis, 1993, Vol.19, p.217-226

HAAS, P

1993

Link zum Volltext

Verfügbarkeit prüfen

Simulation of the extrinsic pathway of the plasmatic clotting system

Haemostasis, 1991, Vol.21 (6), p.329

1991

Link zum Volltext

Verfügbarkeit prüfen

Modulations of thrombin activity by polyelectrolytes in the presence of antithrombin III

Seminars in thrombosis and hemostasis, 1991, Vol.17, p.35-41

1991

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

ThemaHematology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review

Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma

S170: DYNAMIC INTERPLAY BETWEEN TUMOR AND MICRO‐ENVIRONMENT DURING MYELOMA DISEASE PROGRESSION

Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, and MAIA

Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study

Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results

Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS)

Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial

Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Inhibiting MEK in MAPK pathway-activated myeloma

Clinical value of molecular subtyping multiple myeloma using gene expression profiling

Common genetic variants in 11q13.3 and 9q22.33 are associated with molecular subgroups of multiple myeloma

Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120)

The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myeloma

Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma

Serial exome analysis of disease progression in premalignant gammopathies

Hematopoietic progenitor cell collection after autologous transplant for multiple myeloma: low platelet count predicts for poor collection and sole use of resulting graft enhances risk of myelodysplasia

Reply to "Metronomic chemotherapy beyond misconceptions"--Haematologica 2013;98(11):e145

Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma

Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

Report on the International Symposium on Low Molecular Weight Heparins and Related Polysaccharides : Munich, Germany, June 27 and 28, 1991

Simulation of the extrinsic pathway of the plasmatic clotting system

Modulations of thrombin activity by polyelectrolytes in the presence of antithrombin III

Aktive Filter

Suchergebnisse filtern